BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30120543)

  • 21. The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.
    Chen J; Xu X; Wu J; Ling Q; Wang K; Wang W; Zhang M; Shen Y; Zhou L; Xie H; Zheng S
    PLoS One; 2014; 9(3):e93128. PubMed ID: 24676010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma.
    Unek T; Karademir S; Arslan NC; Egeli T; Atasoy G; Sagol O; Obuz F; Akarsu M; Astarcioglu I
    World J Gastroenterol; 2011 Oct; 17(37):4206-12. PubMed ID: 22072852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 years.
    Uchiyama H; Itoh S; Yoshizumi T; Ikegami T; Harimoto N; Soejima Y; Harada N; Morita K; Toshima T; Motomura T; Maehara Y
    HPB (Oxford); 2017 Dec; 19(12):1082-1090. PubMed ID: 28888776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: retrospective study of the Milan and Hangzhou criteria.
    Hu Z; Zhou J; Li Z; Xiang J; Qian Z; Wu J; Zhang M; Zheng S
    PLoS One; 2014; 9(1):e87222. PubMed ID: 24475255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.
    Decaens T; Roudot-Thoraval F; Badran H; Wolf P; Durand F; Adam R; Boillot O; Vanlemmens C; Gugenheim J; Dharancy S; Bernard PH; Boudjema K; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Hilleret MN; Chazouillères O; Cherqui D; Mallat A; Duvoux C
    Liver Int; 2011 Jul; 31(6):792-801. PubMed ID: 21645209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary results of salvage liver transplantation in the patients with unresectable recurrent hepatocellular carcinoma after initial liver resection.
    Liang BY; Huang ZY; Zhou SJ; Hou P; Wang SF; Jiang B; Chen XP
    Hepatogastroenterology; 2014 Oct; 61(135):2014-20. PubMed ID: 25713904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
    Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
    J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of [
    Ye YF; Wang W; Wang T; Yu J; Geng L; Yu SF; Yan S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria.
    Jiang L; Yan LN; Wen TF; Li B; Yang JY
    Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):494-9. PubMed ID: 24103279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies.
    Lei J; Yan L
    J Gastrointest Surg; 2013 Jun; 17(6):1116-22. PubMed ID: 23325342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of Liver Transplantation for Hepatocellular Carcinoma in Terms of Different Criteria: A Single Center Experience.
    Lyu SC; Wang J; Ren ZY; Cao D; He Q
    Curr Med Sci; 2022 Jun; 42(3):548-554. PubMed ID: 35391617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
    Zaydfudim VM; Vachharajani N; Klintmalm GB; Jarnagin WR; Hemming AW; Doyle MB; Cavaness KM; Chapman WC; Nagorney DM
    Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular Carcinoma.
    Jiang L; Liao A; Yan L; Li B; Zhu W; Wen T
    Hepatogastroenterology; 2014 May; 61(131):747-51. PubMed ID: 26176068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
    Mazzaferro V; Llovet JM; Miceli R; Bhoori S; Schiavo M; Mariani L; Camerini T; Roayaie S; Schwartz ME; Grazi GL; Adam R; Neuhaus P; Salizzoni M; Bruix J; Forner A; De Carlis L; Cillo U; Burroughs AK; Troisi R; Rossi M; Gerunda GE; Lerut J; Belghiti J; Boin I; Gugenheim J; Rochling F; Van Hoek B; Majno P;
    Lancet Oncol; 2009 Jan; 10(1):35-43. PubMed ID: 19058754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
    Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
    Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanded criteria for hepatocellular carcinoma after liver transplantation: a 20-year evolution.
    Lai Q; Nudo F; Mennini G; Spoletini G; Morabito V; Levi SG; Melandro F; Guglielmo N; Berloco PB; Rossi M
    Hepatogastroenterology; 2013; 60(128):2039-41. PubMed ID: 24719947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
    Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
    JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.